Transcription of Data Integrity 483’s / Warning Letters
{{id}} {{{paragraph}}}
Example: tourism industry
Data Integrity 483’s / Warning Letters
483 s / Warning Letters related to QC Data Integrity vis-a-vis Regulatory Expectations Ranjit BarshikarQuality by Design / cGMP Metrics .. US QC / Mfg. relatedLagging metrics: Batch Failure Rate Right First Time Out of Specification (OOS) / Laboratory Failure Investigation RatesLeading metrics: Quality System Effectiveness Process Capability Quality Culture Index Quality Culture IndexUS FDA Surprise Inspections .. Until now, FDA s inspections of Indian pharma plants have always been with prior notice. The surprise checks and aggressive surveillance are being considered because of instances of fabrication of documents and human errors . India s growing importance as a hub of Generic producers and rising compliance problems prompt regulator to consider the plan FDA expanded its inspection team in India from 12 to FDA Increasing Inspections.
“483’s / Warning letters related to QC Data Integrity vis-a-vis Regulatory Expectations” Ranjit Barshikar Quality by Design / cGMP Consultant ranjitbarshikar@gmail.com ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: